Viral hepatitis B, defined as inflammation of the liver caused by the hepatitis B virus, is a major public health problem worldwide. The aim of this study was to assess the knowledge and practical attitudes of pregnant women concerning viral hepatitis B. This was a descriptive cross-sectional study conducted over six months in two hospitals in the city of N'Djamena. Pregnant women attending antenatal clinics at the Hôpital de l'Amitié Tchad-Chine or the Hôpital de District Sud de N'Djamena were included. Data were collected using pre-administered questionnaires administered during antenatal consultations. A total of 350 pregnant women were interviewed, of whom 51 had a positive HBsAg result, representing a prevalence of 14.57%. The mean age was 26.4 ±5.6 years. All school levels were represented. In terms of transmission routes: 37.3% of women cited the sexual route, versus 29.4% for the blood route. Mother-to-child transmission was known by 33.3% of pregnant women across all levels of education. However, knowledge was higher (over 70%) among pregnant women with higher levels of education. Nearly 80% of women surveyed were aware of the existence of the vaccine, but less than 1% had been vaccinated. Pregnant women's knowledge of the vaccine remains limited, despite the efforts made in recent years to improve the management of viral hepatitis.
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Viral hepatitis B (HBV) is a common disease and an international public health problem. The modes of transmission are multiple and variable. Infantile transmission, whether horizontal or vertical, is more frequent in tropical environments. Infection acquired in early childhood (horizontal or vertical) often progresses to chronicity
[1]
Aubry P, Gaüzère B A. Viral hepatitis in tropical areas. 2018, Med. Trop (March.), p. 4.
[1]
.
World Health Organization (WHO) estimates that there are 240 million chronic carriers worldwide, over 70% of them in sub-Saharan Africa and East Asia
[2]
European Association for the study of the Liver. Clinical Practice Guideline on the Management of hepatitis B virus infection. 2017; Journal of Hepatology 2017; 67: 370-398.
[2]
.
Prevalence varies according to geographical zone.
Africa south of the Sahara lies in the WHO's high-prevalence zone
[2]
European Association for the study of the Liver. Clinical Practice Guideline on the Management of hepatitis B virus infection. 2017; Journal of Hepatology 2017; 67: 370-398.
[2]
.
In Eastern Europe, a prevalence of 5% has been reported
[3]
Sidibé S, Sacko B Y, Traoré I. 'Prevalence of hepatitis B virus serological markers in pregnant women in the district of Bamako, Mali', Bull Soc Pathol Exot 2001; 94(4): 339 341.
[3]
.
In Northern Europe, the figure was 1.5%
[3]
Sidibé S, Sacko B Y, Traoré I. 'Prevalence of hepatitis B virus serological markers in pregnant women in the district of Bamako, Mali', Bull Soc Pathol Exot 2001; 94(4): 339 341.
[3]
.
In West Africa, prevalences of 14.7%, 11.57% and 11.4% have been reported in Mali, Senegal and Burkina Faso respectively
[4]
Konaté A, H Sow, K Doumbia et al. Epidemiological and serological profile of hepatitis B virus in an urban setting Bamako. Open Journal of Gastroenterology, 2019, 9, 158-163.
[5]
Lo G, Diawara PS, Diouf NN, et al. Prevalence of hepatitis B virus surface antigen (HBsAg) in pregnant women at the laboratory of the Hôpital militaire d'Ouakam (HMO), Dakar. MedAfr Noir 2012; 241-244.
[6]
Sangaré L, Sombié R, Combasséré AW et al. Antenatal transmission of hepatitis B virus in an area of moderate HIV prevalence Ouagadougou, Burkina Faso. Bull Soll Pathol Exot 2009; 102(4): 226-229.
[4-6]
.
In Central Africa, a prevalence of 18.4% has been reported in the far north of Cameroon
[7]
Abdoul R, Amadou H, Eliane O et al. Factors associated with hepatitis B infection among pregnant women in the health facilities of the Mokolo health district/Far North Region Cameroon. PAMJ. 2022; 41: 61. 10.11604.
[7]
.
According to the WHO, Chad is a high-prevalence area. A study carried out in 2022 found a prevalence of 19%
[8]
Ndihokubwaye JB, Maihol T, Naissem J. World Hepatitis Day. WHO July 28, 2022.
[8]
.
However, despite the high national prevalence of viral hepatitis B, few studies have been carried out among pregnant women, the main sources of vertical transmission. Hence the interest of this study, which aims to assess pregnant women's knowledge of viral hepatitis B and thus improve its management.
2. Material and Methods
This was a descriptive cross-sectional study conducted over a period of six (6) months from March 1 to September 1, 2023 in the city of N'Djamena. The gyneco-obstetrics department of the “Hôpital de l'Amitié Tchad Chine” and the maternity ward of the Hôpital de District Sud, commonly known as Hôpital Union, in N'Djamena served as the setting. Sampling was consecutive and exhaustive.
Pregnant women residing in N'Djamena and attending antenatal care at one of the study hospitals were included with their consent. Health professionals (nurse, midwife, doctor or pharmacist) and non-consenting women were not included.
Data were collected using a multivariate questionnaire administered by an investigator, covering socio-demographic data, knowledge, attitudes and practices in relation to viral hepatitis B. The questionnaire was written and administered in English, French and Spanish. The questionnaire was written and administered in French for those with a medium or high level of education. For those with little or no French education, the questionnaire was translated orally into the national language, either local Arabic or Ngambaye, according to the respondent's preference. Data were collected during prenatal consultations. Data were processed using SPSS software.
3. Results
During the study period, a total of 502 women were seen in antenatal consultation (ANC), 350 of whom agreed to answer the questionnaires and thus participate in the study, i.e. a 69.7% participation rate. Fifty-one (51) of the 350 had a positive HBsAg result, i.e. a prevalence of 14.57%.
3.1. Socio-demographic Data
Age
The mean age was 26.4±5.6 years, with extremes of 15 and 43 years.
The 20-30 age group accounted for over 70%. Pregnant women with secondary education were the most represented (46.6%).
Table 1. Pregnant women by socio-demographic characteristics.
Socio-demographic characteristics
Ages (years)
Number (N)
Percentage (%)
[15-20[
48
13,7
[20-25[
77
22,0
[25-30[
105
30,0
[30-35[
82
23,4
[35-40[
31
8,9
[40-45[
7
2,0
Educational level
No
17
4,8
Primary
137
39,1
Secondary
163
46,6
Higher
33
9,4
3.2. Pregnant Women's Knowledge of HBsAg
Knowledge of viral hepatitis B was variable but generally low. One hundred and sixty-eight (168) pregnant women, i.e. 48% of the total, were unaware of the causative agent of the disease. In terms of transmission routes, sexual transmission was known by 37.1% of pregnant women at all levels. However, knowledge of this route of transmission was better among women in higher grades. (33/33). Mother-to-child transmission was known by 25% of women at all levels of education.
Table 2. Distribution of pregnant women according to general knowledge of HBV.
General knowledge HBV
Number (n)
Percentage (%)
Causal agent
Good response
All levels combined
182
52
Routes of sexual transmission
All levels
130
37,1
Top level
33
100
Mother-to-child transmission
All levels
89
25,4
Upper level
27/33
78,8
Fecal-oral route (saliva)
All levels
42
12,0
Upper level
31
93,9
Blood transmission
All levels
91
26,3
Upper level
33
100
Existence of effective modern
All levels
73
20,8
Upper level
21
63,6
Existence of vaccine
All levels
279
79,7
Upper level
33
100
Average PMTCT vaccine
All levels
97
27,7
Highest level
27
818
3.3. Pregnant Women's Practices with Regard to Viral Hepatitis B
Of the 502 women followed up for ANC during the study period, the 350 who agreed to answer the questionnaires had all been screened for HBV, HCV and HIV. Of the remaining 152, 61 knew their status (screened during previous pregnancies or during a health check-up). Almost all women had not been vaccinated against HBV (99.6%).
4. Discussion
Viral hepatitis B, a major public health problem, no longer needs to be demonstrated, especially in sub-Saharan Africa
[1]
Aubry P, Gaüzère B A. Viral hepatitis in tropical areas. 2018, Med. Trop (March.), p. 4.
[2]
European Association for the study of the Liver. Clinical Practice Guideline on the Management of hepatitis B virus infection. 2017; Journal of Hepatology 2017; 67: 370-398.
[1, 2]
. The knowledge and practical attitudes of pregnant women, the main source of transmission, certainly influence the transmission of the disease.
In this series, 502 women were seen in prenatal consultation at the two study hospitals, 350 of whom agreed to take part in the study, and all were screened for hepatitis B free of charge, representing a 69.6% participation rate. This participation rate calls on us to raise awareness among all those involved in the care of parturients, in order to meet WHO recommendations that all pregnant women should be screened for HBsAg. Of the pregnant women screened, 51 were HBsAg positive, representing a prevalence of 14.57%.
This result is in line with the literature, which classifies most sub-Saharan African countries, including Chad, as high-prevalence zones.
Similar results were reported by:
Khadidjatou S et al. in Benin in 2019 who reported 14.02%
[9]
Khadidjatou SA, Rachidi S. I, Honorat S et al. Seroprevalence and factors associated with hepatitis B in pregnant women in Parakou, Republic of Benin. Pan Afr Med J 2019; 33: 226.
[9]
.
Doumbia K el al. in Mali found 17% of HBsAg-positive cases in women in 2022
[10]
Doumbia K, Sow H, Dicko M Y et al. Hepatitis B virus infection in pregnant women in the gyneco-obstetric department of Centre Hospitalier Gabriel TOURE. Mali Médical; 2022 TOME XXXVII: 56-60.
[10]
.
Abdoul et al. in 2020 reported 18.4% in Cameroon
[7]
Abdoul R, Amadou H, Eliane O et al. Factors associated with hepatitis B infection among pregnant women in the health facilities of the Mokolo health district/Far North Region Cameroon. PAMJ. 2022; 41: 61. 10.11604.
[7]
. It should be noted that prevalence varies from one geographical area to another.
In Morocco, it was 2.35% according to Sbiti M et al
[11]
Sbiti M, Khalki H, Benbella et al. Seroprevalence of HBsAg in pregnant women in central Morocco. Pan Afr Med J 2016; 24: 187.
[11]
.
This difference could be explained by environmental factors linked to geographical location, classifying countries into high, medium and low prevalence zones
[12]
Ott JJ, Stevens GA, Groeger J et al. Global epidemiology of hepatitis B virus infection: new estimates of Age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012; 30(12): 2212-2219.
[12]
.
The mean age was 26.4+/-5.6 with extremes of 15 and 43 years. Our results are similar to those of Sbiti M et al. in Morocco and Boushab M in Mauritania, who found an average age of 28+/-6 and 28+/-7 respectively
[11]
Sbiti M, Khalki H, Benbella et al. Seroprevalence of HBsAg in pregnant women in central Morocco. Pan Afr Med J 2016; 24: 187.
[13]
Boushab M, Mohamed DA, Sidi E. Prevalence of HBsAg in pregnant women at the Centre Hospitalier Mère-Enfant of Nouakchott, Mauritania. Rev Mali Infect Microbiol 2022; 17(1): 72-6.
[11, 13]
. The young age of the patients can be explained by the early acquisition of the infection through vertical or horizontal transmission during childhood, on the one hand, and by the youthfulness of the African population on the other, especially in this context, where women of childbearing age are relatively young.
In terms of level of education, almost half have secondary education, and over 39% have primary education. This result is lower than in the Benin study, where secondary education accounted for 52.8% of cases
[9]
Khadidjatou SA, Rachidi S. I, Honorat S et al. Seroprevalence and factors associated with hepatitis B in pregnant women in Parakou, Republic of Benin. Pan Afr Med J 2019; 33: 226.
[9]
.
Knowledge of the disease varies according to the level of schooling. Only 52% of pregnant women surveyed knew the causative agent of the disease. Of the remaining 48%, some believe that the illness is caused by bacteria, while others claim that the disease is the result of a divine spell, which is mystical in our context. In terms of contamination routes, sexual transmission was known to be the source of contamination for 37.1%, followed by blood for 26.3%, all levels of education combined. It should be emphasized that knowledge is higher among pregnant women with higher levels of education (100%). Mother-to-child transmission, the main source of transmission in Africa and East Asia, was known in only 25% of cases, all levels combined. In France, this route was known by over 80% of the women surveyed
[14]
Cécile Brouard, Arnaud Gautier, Leïla Saboni et al. Knowledge, perceptions and practices regarding hepatitis B and C in metropolitan France in 2010. Bulletin épidémiologique 2012; 29/30: 331-53.1.
[14]
. This study shows that higher levels of education improve knowledge of the condition. Over 78% of women in higher education recognized that the hepatitis B virus can be transmitted from mother to child, compared with 25% of the study population as a whole.
Njoya et al. found 25.9% for the vertical route
[15]
Njoya. O; Essi. MJ; Ongolo. B et al. Connaissance, perceptions et pratiques des femmes eneintes vis à vis de l'hépatite B en milieu urbain au Cameroun. Healt Sci: vol 14(12) June 2013.
[15]
. These differences could be explained by the educational levels of the study population. Although not recognized as a source of hepatitis B transmission, the salivary route continues to be cited by African populations (who probably confuse hepatitis B with hepatitis A). In our series, 12% of women believe that hepatitis B is transmitted by saliva.
In practical terms, 80% of women surveyed at all levels were aware of the existence of the hepatitis B vaccine, and more than 27% recognized its importance in preventing mother-to-child transmission of the virus. Despite this high level of awareness of the vaccine, less than 1% of women claim to be vaccinated against HBV. With regard to the importance of PMTCT, our result is lower than that of the Cameroon study, where over 40% of women were aware of the importance of prevention of mother-to-child transmission (PMTCT)
[15]
Njoya. O; Essi. MJ; Ongolo. B et al. Connaissance, perceptions et pratiques des femmes eneintes vis à vis de l'hépatite B en milieu urbain au Cameroun. Healt Sci: vol 14(12) June 2013.
[15]
.
5. Conclusion
This study shows that overall knowledge of hepatitis B among pregnant women in N'Djamena is limited. Pregnant women with a high level of education, however, had a better knowledge. Efforts still need to be made to raise awareness and educate young girls, who are potential candidates for childbearing. Further work would be useful to better define the problem.
Abbreviations
WHO
World Health Organization
PMTCT
Prevention of Mother-to-Child Transmission
Conflicts of Interest
The authors declare no conflicts of interest.
References
[1]
Aubry P, Gaüzère B A. Viral hepatitis in tropical areas. 2018, Med. Trop (March.), p. 4.
[2]
European Association for the study of the Liver. Clinical Practice Guideline on the Management of hepatitis B virus infection. 2017; Journal of Hepatology 2017; 67: 370-398.
[3]
Sidibé S, Sacko B Y, Traoré I. 'Prevalence of hepatitis B virus serological markers in pregnant women in the district of Bamako, Mali', Bull Soc Pathol Exot 2001; 94(4): 339 341.
[4]
Konaté A, H Sow, K Doumbia et al. Epidemiological and serological profile of hepatitis B virus in an urban setting Bamako. Open Journal of Gastroenterology, 2019, 9, 158-163.
[5]
Lo G, Diawara PS, Diouf NN, et al. Prevalence of hepatitis B virus surface antigen (HBsAg) in pregnant women at the laboratory of the Hôpital militaire d'Ouakam (HMO), Dakar. MedAfr Noir 2012; 241-244.
[6]
Sangaré L, Sombié R, Combasséré AW et al. Antenatal transmission of hepatitis B virus in an area of moderate HIV prevalence Ouagadougou, Burkina Faso. Bull Soll Pathol Exot 2009; 102(4): 226-229.
[7]
Abdoul R, Amadou H, Eliane O et al. Factors associated with hepatitis B infection among pregnant women in the health facilities of the Mokolo health district/Far North Region Cameroon. PAMJ. 2022; 41: 61. 10.11604.
[8]
Ndihokubwaye JB, Maihol T, Naissem J. World Hepatitis Day. WHO July 28, 2022.
[9]
Khadidjatou SA, Rachidi S. I, Honorat S et al. Seroprevalence and factors associated with hepatitis B in pregnant women in Parakou, Republic of Benin. Pan Afr Med J 2019; 33: 226.
[10]
Doumbia K, Sow H, Dicko M Y et al. Hepatitis B virus infection in pregnant women in the gyneco-obstetric department of Centre Hospitalier Gabriel TOURE. Mali Médical; 2022 TOME XXXVII: 56-60.
[11]
Sbiti M, Khalki H, Benbella et al. Seroprevalence of HBsAg in pregnant women in central Morocco. Pan Afr Med J 2016; 24: 187.
[12]
Ott JJ, Stevens GA, Groeger J et al. Global epidemiology of hepatitis B virus infection: new estimates of Age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012; 30(12): 2212-2219.
[13]
Boushab M, Mohamed DA, Sidi E. Prevalence of HBsAg in pregnant women at the Centre Hospitalier Mère-Enfant of Nouakchott, Mauritania. Rev Mali Infect Microbiol 2022; 17(1): 72-6.
[14]
Cécile Brouard, Arnaud Gautier, Leïla Saboni et al. Knowledge, perceptions and practices regarding hepatitis B and C in metropolitan France in 2010. Bulletin épidémiologique 2012; 29/30: 331-53.1.
[15]
Njoya. O; Essi. MJ; Ongolo. B et al. Connaissance, perceptions et pratiques des femmes eneintes vis à vis de l'hépatite B en milieu urbain au Cameroun. Healt Sci: vol 14(12) June 2013.
Habkreo, M., Dahainssala, M., Mahamat, B., Ngaré, A. A., Hachim, M. A., et al. (2024). Practical Knowledge and Attitudes of Pregnant Women About Viral Hepatitis B in N'djamena. American Journal of Internal Medicine, 12(5), 100-103. https://doi.org/10.11648/j.ajim.20241205.15
Habkreo, M.; Dahainssala, M.; Mahamat, B.; Ngaré, A. A.; Hachim, M. A., et al. Practical Knowledge and Attitudes of Pregnant Women About Viral Hepatitis B in N'djamena. Am. J. Intern. Med.2024, 12(5), 100-103. doi: 10.11648/j.ajim.20241205.15
Habkreo M, Dahainssala M, Mahamat B, Ngaré AA, Hachim MA, et al. Practical Knowledge and Attitudes of Pregnant Women About Viral Hepatitis B in N'djamena. Am J Intern Med. 2024;12(5):100-103. doi: 10.11648/j.ajim.20241205.15
@article{10.11648/j.ajim.20241205.15,
author = {Mayanna Habkreo and Maïré Dahainssala and Badawi Mahamat and Adama Ahmed Ngaré and Mahamat Ali Hachim and Goumbo Nedjim and Moussa Elefi and Abdramane Kossou and Ali Mahamat Moussa},
title = {Practical Knowledge and Attitudes of Pregnant Women About Viral Hepatitis B in N'djamena
},
journal = {American Journal of Internal Medicine},
volume = {12},
number = {5},
pages = {100-103},
doi = {10.11648/j.ajim.20241205.15},
url = {https://doi.org/10.11648/j.ajim.20241205.15},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajim.20241205.15},
abstract = {Viral hepatitis B, defined as inflammation of the liver caused by the hepatitis B virus, is a major public health problem worldwide. The aim of this study was to assess the knowledge and practical attitudes of pregnant women concerning viral hepatitis B. This was a descriptive cross-sectional study conducted over six months in two hospitals in the city of N'Djamena. Pregnant women attending antenatal clinics at the Hôpital de l'Amitié Tchad-Chine or the Hôpital de District Sud de N'Djamena were included. Data were collected using pre-administered questionnaires administered during antenatal consultations. A total of 350 pregnant women were interviewed, of whom 51 had a positive HBsAg result, representing a prevalence of 14.57%. The mean age was 26.4 ±5.6 years. All school levels were represented. In terms of transmission routes: 37.3% of women cited the sexual route, versus 29.4% for the blood route. Mother-to-child transmission was known by 33.3% of pregnant women across all levels of education. However, knowledge was higher (over 70%) among pregnant women with higher levels of education. Nearly 80% of women surveyed were aware of the existence of the vaccine, but less than 1% had been vaccinated. Pregnant women's knowledge of the vaccine remains limited, despite the efforts made in recent years to improve the management of viral hepatitis.
},
year = {2024}
}
TY - JOUR
T1 - Practical Knowledge and Attitudes of Pregnant Women About Viral Hepatitis B in N'djamena
AU - Mayanna Habkreo
AU - Maïré Dahainssala
AU - Badawi Mahamat
AU - Adama Ahmed Ngaré
AU - Mahamat Ali Hachim
AU - Goumbo Nedjim
AU - Moussa Elefi
AU - Abdramane Kossou
AU - Ali Mahamat Moussa
Y1 - 2024/10/31
PY - 2024
N1 - https://doi.org/10.11648/j.ajim.20241205.15
DO - 10.11648/j.ajim.20241205.15
T2 - American Journal of Internal Medicine
JF - American Journal of Internal Medicine
JO - American Journal of Internal Medicine
SP - 100
EP - 103
PB - Science Publishing Group
SN - 2330-4324
UR - https://doi.org/10.11648/j.ajim.20241205.15
AB - Viral hepatitis B, defined as inflammation of the liver caused by the hepatitis B virus, is a major public health problem worldwide. The aim of this study was to assess the knowledge and practical attitudes of pregnant women concerning viral hepatitis B. This was a descriptive cross-sectional study conducted over six months in two hospitals in the city of N'Djamena. Pregnant women attending antenatal clinics at the Hôpital de l'Amitié Tchad-Chine or the Hôpital de District Sud de N'Djamena were included. Data were collected using pre-administered questionnaires administered during antenatal consultations. A total of 350 pregnant women were interviewed, of whom 51 had a positive HBsAg result, representing a prevalence of 14.57%. The mean age was 26.4 ±5.6 years. All school levels were represented. In terms of transmission routes: 37.3% of women cited the sexual route, versus 29.4% for the blood route. Mother-to-child transmission was known by 33.3% of pregnant women across all levels of education. However, knowledge was higher (over 70%) among pregnant women with higher levels of education. Nearly 80% of women surveyed were aware of the existence of the vaccine, but less than 1% had been vaccinated. Pregnant women's knowledge of the vaccine remains limited, despite the efforts made in recent years to improve the management of viral hepatitis.
VL - 12
IS - 5
ER -
Gastroenterology, Internal Medicine Department, National Reference Teaching Hospital, N’Djamena, Chad; Department of Medicine, N'Djamena Faculty of Human Health Sciences of N’Djamena, N’Djamena, Chad
Gastroenterology, Internal Medicine Department, National Reference Teaching Hospital, N’Djamena, Chad
Badawi Mahamat
Gastroenterology, Internal Medicine Department, National Reference Teaching Hospital, N’Djamena, Chad
Adama Ahmed Ngaré
Gastroenterology, Internal Medicine Department, National Reference Teaching Hospital, N’Djamena, Chad; Department of Medicine, N'Djamena Faculty of Human Health Sciences of N’Djamena, N’Djamena, Chad
Mahamat Ali Hachim
Gastroenterology, Internal Medicine Department, National Reference Teaching Hospital, N’Djamena, Chad
Goumbo Nedjim
Gastroenterology, Internal Medicine Department, National Reference Teaching Hospital, N’Djamena, Chad
Moussa Elefi
Gastroenterology, Internal Medicine Department, National Reference Teaching Hospital, N’Djamena, Chad
Abdramane Kossou
Gastroenterology, Internal Medicine Department, National Reference Teaching Hospital, N’Djamena, Chad
Ali Mahamat Moussa
Gastroenterology, Internal Medicine Department, National Reference Teaching Hospital, N’Djamena, Chad; Department of Medicine, N'Djamena Faculty of Human Health Sciences of N’Djamena, N’Djamena, Chad
Habkreo, M., Dahainssala, M., Mahamat, B., Ngaré, A. A., Hachim, M. A., et al. (2024). Practical Knowledge and Attitudes of Pregnant Women About Viral Hepatitis B in N'djamena. American Journal of Internal Medicine, 12(5), 100-103. https://doi.org/10.11648/j.ajim.20241205.15
Habkreo, M.; Dahainssala, M.; Mahamat, B.; Ngaré, A. A.; Hachim, M. A., et al. Practical Knowledge and Attitudes of Pregnant Women About Viral Hepatitis B in N'djamena. Am. J. Intern. Med.2024, 12(5), 100-103. doi: 10.11648/j.ajim.20241205.15
Habkreo M, Dahainssala M, Mahamat B, Ngaré AA, Hachim MA, et al. Practical Knowledge and Attitudes of Pregnant Women About Viral Hepatitis B in N'djamena. Am J Intern Med. 2024;12(5):100-103. doi: 10.11648/j.ajim.20241205.15
@article{10.11648/j.ajim.20241205.15,
author = {Mayanna Habkreo and Maïré Dahainssala and Badawi Mahamat and Adama Ahmed Ngaré and Mahamat Ali Hachim and Goumbo Nedjim and Moussa Elefi and Abdramane Kossou and Ali Mahamat Moussa},
title = {Practical Knowledge and Attitudes of Pregnant Women About Viral Hepatitis B in N'djamena
},
journal = {American Journal of Internal Medicine},
volume = {12},
number = {5},
pages = {100-103},
doi = {10.11648/j.ajim.20241205.15},
url = {https://doi.org/10.11648/j.ajim.20241205.15},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajim.20241205.15},
abstract = {Viral hepatitis B, defined as inflammation of the liver caused by the hepatitis B virus, is a major public health problem worldwide. The aim of this study was to assess the knowledge and practical attitudes of pregnant women concerning viral hepatitis B. This was a descriptive cross-sectional study conducted over six months in two hospitals in the city of N'Djamena. Pregnant women attending antenatal clinics at the Hôpital de l'Amitié Tchad-Chine or the Hôpital de District Sud de N'Djamena were included. Data were collected using pre-administered questionnaires administered during antenatal consultations. A total of 350 pregnant women were interviewed, of whom 51 had a positive HBsAg result, representing a prevalence of 14.57%. The mean age was 26.4 ±5.6 years. All school levels were represented. In terms of transmission routes: 37.3% of women cited the sexual route, versus 29.4% for the blood route. Mother-to-child transmission was known by 33.3% of pregnant women across all levels of education. However, knowledge was higher (over 70%) among pregnant women with higher levels of education. Nearly 80% of women surveyed were aware of the existence of the vaccine, but less than 1% had been vaccinated. Pregnant women's knowledge of the vaccine remains limited, despite the efforts made in recent years to improve the management of viral hepatitis.
},
year = {2024}
}
TY - JOUR
T1 - Practical Knowledge and Attitudes of Pregnant Women About Viral Hepatitis B in N'djamena
AU - Mayanna Habkreo
AU - Maïré Dahainssala
AU - Badawi Mahamat
AU - Adama Ahmed Ngaré
AU - Mahamat Ali Hachim
AU - Goumbo Nedjim
AU - Moussa Elefi
AU - Abdramane Kossou
AU - Ali Mahamat Moussa
Y1 - 2024/10/31
PY - 2024
N1 - https://doi.org/10.11648/j.ajim.20241205.15
DO - 10.11648/j.ajim.20241205.15
T2 - American Journal of Internal Medicine
JF - American Journal of Internal Medicine
JO - American Journal of Internal Medicine
SP - 100
EP - 103
PB - Science Publishing Group
SN - 2330-4324
UR - https://doi.org/10.11648/j.ajim.20241205.15
AB - Viral hepatitis B, defined as inflammation of the liver caused by the hepatitis B virus, is a major public health problem worldwide. The aim of this study was to assess the knowledge and practical attitudes of pregnant women concerning viral hepatitis B. This was a descriptive cross-sectional study conducted over six months in two hospitals in the city of N'Djamena. Pregnant women attending antenatal clinics at the Hôpital de l'Amitié Tchad-Chine or the Hôpital de District Sud de N'Djamena were included. Data were collected using pre-administered questionnaires administered during antenatal consultations. A total of 350 pregnant women were interviewed, of whom 51 had a positive HBsAg result, representing a prevalence of 14.57%. The mean age was 26.4 ±5.6 years. All school levels were represented. In terms of transmission routes: 37.3% of women cited the sexual route, versus 29.4% for the blood route. Mother-to-child transmission was known by 33.3% of pregnant women across all levels of education. However, knowledge was higher (over 70%) among pregnant women with higher levels of education. Nearly 80% of women surveyed were aware of the existence of the vaccine, but less than 1% had been vaccinated. Pregnant women's knowledge of the vaccine remains limited, despite the efforts made in recent years to improve the management of viral hepatitis.
VL - 12
IS - 5
ER -
Share This Article
Twitter
Linked In
Facebook
Copy
Download